You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 11, November 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Extract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Retinal/ Chorioretinal Disorders
 •Vitreous Disorders
 •Laser Surgery
 •Alert me on articles by topic

Progression of Familial Exudative Vitreoretinopathy After Laser Treatment

Arch Ophthalmol. 2004;122:1717-1719.

Familial exudative vitreoretinopathy (FEVR) is an inherited vitreoretinal dystrophy with a variable clinical course. Early disease with no retinal detachment has been shown to respond well to primary laser treatment.1 The following case manifested symmetrically but responded asymmetrically to appropriate and aggressive laser treatment.

Report of a Case

A 17-month-old girl was referred to the Vitreoretinal Surgical Service of the Bascom Palmer Eye Institute, Miami, Fla, for a strong family history of FEVR. The patient was delivered at full term, her medical history was unremarkable, and her developmental milestones were intact. She had no previous ocular history, but her mother noticed that the patient was bringing objects close to her face, squinting, and bumping into things. External examination revealed primary alternating esotropia. Dilated retinal examination of both eyes showed symmetric anterior ischemic retinopathy and secondary ridge neovascularization consistent with FEVR. Focal traction in this region was noted. The patient was treated with large spot–size laser ablation by indirect ophthalmoscopy to the anterior ischemic retina. One month following treatment, the patient had good regression of the neovascularization (Figure 1). Despite this regression, extramacular vitreoretinal traction alterations persisted in both eyes. Four months later, there was minimal progression of traction in the left eye with a localized area of extramacular schisis formation. The right eye showed progressive tractional alterations through the macula with development of a falciform retinal fold (Figure 2).



View larger version (34K):
[in this window]
[in a new window]
Figure 1. Familial exudative vitreoretinopathy 1 month after laser therapy. There has been complete resolution of peripheral neovascularization with mild peripheral tractional changes in both eyes. A, Right eye. B, Left eye.




View larger version (34K):
[in this window]
[in a new window]
Figure 2. Familial exudative vitreoretinopathy 4 months after laser therapy. There is progressive tractional alteration with falciform fold formation in the right eye (A) but minimal change in the left eye (B).



Comment

Familial exudative vitreoretinopathy is an inherited vitreoretinal dystrophy characterized by premature arrest of vascularization of the peripheral retina. There is a broad spectrum of disease involvement from mild avascular retinal changes that are slowly progressive to rapidly progressive tractional and/or exudative changes with total retinal detachment early in life. There has never been a prospective clinical trial for the management of active FEVR in infancy. Avascular retinal periphery with extraretinal vascularization alone has been shown to respond to laser treatment in retrospective reviews.1 There is a broad spectrum of treatment response, and FEVR does not always respond like retinopathy of prematurity when the avascular retina is treated with laser. Advanced disease with retinal detachment usually requires scleral buckling and/or vitreous surgery.2

Previous authors have observed that patients whose onset of symptoms is before 3 years of age are at increased risk of poor visual out come.3 It appears that older patients have a better prognosis because they are likely to have asymmetric disease with only 1 eye severely affected. However, loss of good visual acuity may occur even well into adulthood.

Our patient was diagnosed at 17 months of age with symmetric anterior ischemic retinopathy and secondary ridge neovascularization with limited traction. There was no evidence of retinal detachment or falciform fold at initial examination. Both eyes were treated with near confluent laser to the avascular retina. While both eyes showed regression of arborizing vessels, tractional changes progressed in 1 eye with the development of a falciform retinal fold. Pendergast and Trese1 described 7 patients who had similar disease involvement on initial examination as  our patient. Only 1 of these patients progressed to retinal detachment after laser treatment, requiring surgical intervention. Surgical intervention was considered in our patient; however, falciform detachments are difficult to eradicate and visual outcomes are often poor. Our experience emphasizes the possibility for disease progression despite appropriate laser therapy and initial vascular involution.


AUTHOR INFORMATION

Correspondence: Dr Murray, Bascom Palmer Eye Institute, 900 NW 17th St, Miami, FL 33136 (tmurray{at}med.miami.edu).

Financial Disclosure: None.

Ron Margolis, BA; Stephen S. Couvillion, MD; Elias C. Mavrofrides, MD; Ditte Hess, CRA; Timothy G. Murray, MD


REFERENCES

1. Pendergast SD, Trese MT. Familial exudative vitreoretinopathy: results of surgical management. Ophthalmology. 1998;105:1015-1023. FULL TEXT | ISI | PUBMED
2. Shaikh S, Trese MT. Retinal reattachment facilitated by short-term perfluorocarbon liquid tamponade in a case of fever and rhegmatogenous retinal detachment. Retina. 2002;22:674-676. PUBMED
3. Shubert A, Tasman W. Familial exudative vitreoretinopathy: surgical intervention and visual acuity outcomes. Graefes Arch Clin Exp Ophthalmol. 1997;235:490-493. PUBMED

SECTION EDITOR: W. RICHARD GREEN, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.